<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04924985</url>
  </required_header>
  <id_info>
    <org_study_id>20-00354</org_study_id>
    <nct_id>NCT04924985</nct_id>
  </id_info>
  <brief_title>Goal-directed CPR Using Cerebral Oximetry</brief_title>
  <official_title>Goal-Directed Cardiopulmonary Resuscitation in Cardiac Arrest Using a Novel Physiological Target</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NYU Langone Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>NYU Langone Health</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The proposed study is a single-center, randomized controlled pilot trial of adults who suffer&#xD;
      in-hospital cardiac arrests. Using cerebral oxygenation and end-tidal carbon dioxide&#xD;
      physiological targets to predict survival and neurological outcome, the impact of&#xD;
      physiological-feedback CPR will be assessed. 150 adult patients who have a cardiac arrest&#xD;
      event at NYU Tisch Hospital will be randomized to one of two treatment groups: (1)&#xD;
      Physiological-Feedback CPR or (2) Non-Physiological (Audiovisual) Feedback CPR.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 15, 2021</start_date>
  <completion_date type="Anticipated">July 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of Return of Spontaneous Circulation (ROSC)</measure>
    <time_frame>Day 0</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cerebral Performance Category (CPC) Score</measure>
    <time_frame>Day 1-2</time_frame>
    <description>Total range of score is 1 (Good cerebral performance) to 5 (Brain death). The higher the score, the worse the clinical condition.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cerebral Performance Category (CPC) Score</measure>
    <time_frame>Day 30</time_frame>
    <description>Total range of score is 1 (Good cerebral performance) to 5 (Brain death). The higher the score, the worse the clinical condition.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in mean rSO2 during CPR as markers of the quality of resuscitation</measure>
    <time_frame>Day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in mean ETCO2 during CPR as markers of the quality of resuscitation</measure>
    <time_frame>Day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Release of interleukin (IL)-6</measure>
    <time_frame>Day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Release of Lactate</measure>
    <time_frame>Day 0</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Ischemia</condition>
  <condition>Reperfusion Injury</condition>
  <arm_group>
    <arm_group_label>Physiological Feedback CPR</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-Physiological (Audiovisual) Feedback CPR</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Non-Physiological Feedback CPR</intervention_name>
    <description>Non-physiologically guided CPR using AV feedback (integrated into defibrillators)</description>
    <arm_group_label>Non-Physiological (Audiovisual) Feedback CPR</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Physiological Feedback CPR</intervention_name>
    <description>Physiological feedback CPR using an optimal regional O2 Saturation (rSO2), End-tidal CO2 (ETCO2) or combined (rSO2/ETCO2) target</description>
    <arm_group_label>Physiological Feedback CPR</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. In-hospital cardiac arrest patient&#xD;
&#xD;
          2. Age ≥18 years&#xD;
&#xD;
          3. Age &lt;80 years&#xD;
&#xD;
          4. CPR lasting ≥5 minutes&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients &lt; 18 years of age or &gt; 80 years of age&#xD;
&#xD;
          2. Out of hospital cardiac arrest patients&#xD;
&#xD;
          3. ≥3 acute organ failures (defined as acute renal failure requiring dialysis, fulminant&#xD;
             liver failure i.e. liver failure with INR≥1.5, respiratory failure requiring&#xD;
             mechanical ventilation)&#xD;
&#xD;
          4. Repeat in-hospital cardiac arrest event within 14 days of a prior cardiac arrest&#xD;
&#xD;
          5. Presence of known raised intracranial pressure&#xD;
&#xD;
          6. Presence of known traumatic brain injury or subarachnoid hemorrhage &lt;14 days old,&#xD;
             frontal lobe brain tumors or subdural hemorrhage&#xD;
&#xD;
          7. Hyperbilirubinemia &gt;1.0 mg/dl (based on the absorption of near-infrared light by&#xD;
             bilirubin)&#xD;
&#xD;
          8. Resuscitation using extra-corporeal membrane oxygenation (ECMO)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sam Parnia, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>NYU Langone Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anelly Gonzalez</last_name>
    <phone>646-501-6923</phone>
    <email>Anelly.Gonzales@nyulangone.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tara Keshavarz</last_name>
    <phone>646-501-0122</phone>
    <email>Tara.Keshavarz@nyulangone.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>NYU Langone Health</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Anelly Gonzalez</last_name>
      <email>Anelly.Gonzales@nyulangone.org</email>
    </contact>
    <contact_backup>
      <last_name>Tara Keshavarz</last_name>
      <email>Tara.Keshavarz@nyulangone.org</email>
    </contact_backup>
    <investigator>
      <last_name>Sam Parnia, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 10, 2021</study_first_submitted>
  <study_first_submitted_qc>June 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 14, 2021</study_first_posted>
  <last_update_submitted>June 11, 2021</last_update_submitted>
  <last_update_submitted_qc>June 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>CPR</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Reperfusion Injury</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices) will be shared upon reasonable request.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_time_frame>Beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research.</ipd_time_frame>
    <ipd_access_criteria>The investigator who proposed to use the data will have access to the data upon reasonable request. Requests should be directed to Sam.Parnia@nyulangone.org. To gain access, data requestors will need to sign a data access agreement.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

